Blood Cell CountLeukocyte CountAntineoplastic Combined Chemotherapy ProtocolsErythrocyte CountChemotherapy, AdjuvantCell CountBlood CellsCD4 Lymphocyte CountPlatelet CountTreatment OutcomeAntineoplastic AgentsCombined Modality TherapyLeukocytosisErythrocytesCyclophosphamidePrognosisCisplatinHematologic TestsDoxorubicinHematocritSurvival AnalysisTime FactorsDisease-Free SurvivalProspective StudiesHemoglobinsSurvival RateDrug Administration ScheduleHIV InfectionsEtoposideLymphocyte CountFollow-Up StudiesNeoadjuvant TherapyLeukopeniaBiological MarkersLeukocytesBreast NeoplasmsMethotrexateRisk FactorsC-Reactive ProteinNeoplasm StagingErythrocyte IndicesCohort StudiesCytarabinePredictive Value of TestsPrecursor Cell Lymphoblastic Leukemia-LymphomaLung NeoplasmsBone MarrowGranulocyte Colony-Stimulating FactorThrombocytopeniaNeoplasmsLeukemia, Myeloid, AcuteNeutropeniaViral LoadRetrospective StudiesCarboplatinPaclitaxelMultivariate AnalysisDose-Response Relationship, DrugVinblastineAcute DiseaseInduction ChemotherapyLeukemoid ReactionNeoplasm Recurrence, LocalRecurrenceHematologyDaunorubicinAnti-HIV AgentsBleomycinTaxoidsAnemiaReticulocyte CountBlood SedimentationFeverDisease ProgressionCerebrospinal FluidSpinal PunctureNeutrophilsDrug Resistance, NeoplasmIfosfamideKaplan-Meier EstimateHematopoietic Stem Cell TransplantationDeoxycytidineAntimetabolites, AntineoplasticLeukemia, MyeloidHematopoiesisOrganoplatinum CompoundsHematologic DiseasesBlood Chemical AnalysisAntiretroviral Therapy, Highly ActiveAge FactorsAntibiotics, AntineoplasticSensitivity and SpecificityTransplantation, AutologousLymphocytesErythrocyte TransfusionSalvage TherapyFlow CytometryAntineoplastic Agents, AlkylatingHIV-1Hematopoietic Stem Cells